{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} A Review of Chronic Comorbidities in Adults Living With HIV: State of the Science

Activity Steps

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Choose diagnostic tests that identify the risk for or presence of selected chronic comorbidities of PLWH.
  2. Explain strategies to prevent atherosclerotic cardiovascular disease (ASCVD), anal cancer, and diabetes mellitus (DM) in PLWH.
  3. Recognize treatment approaches for ASCVD and hepatocellular carcinoma (HCC).
  4. Identify risk factors for selected comorbidities of PLWH.
Price: $29.95


  • ANCC 3.5 CH / 2.5 APH
  • DC - BON 3.5 CH
  • FL - BON 3.5 CH
  • GA - BON 3.5 CH

Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.

Awarded Advanced Pharmacology Hours

Test Code: JANAC0521B
Published: May/Jun 2021
Expires: 6/2/2023
Required Passing Score: 7/10 (70%)
Authors: Allison R. Webel, PhD, RN, FAAN; Julie Schexnayder, DNP, MPH, ACNP-BC; Patricia A. Cioe, PhD, RN; Julie A. Zun? iga, PhD, PhD, FAAN